Coagulase-negative staphylococci as a significant fact of generalization of infection in persons with a burdened comorbid background

Cover Page

Cite item

Full Text

Abstract

Since the era of the widespread introduction of antibiotics into the human sphere of activity, the problem of antimicrobial resistance has become an urgent and very important topic around the world. Recently, coagulasonegative staphylococci (CoNS), which are representatives of opportunistic microorganisms of the microbiome of the skin and mucous membranes of healthy people, have made a certain contribution to its progression. For a long time, they did not pose a threat to patients, but in recent decades among microorganisms they have been seeded in more than two-thirds of patients with postoperative mediastinitis, catheter-associated infections, as well as from wounds of the neck vessels and the inguinal region separated by pacemaker beds. This paper discloses, using clinical examples, the significance of CoNS in the formation of systemic inflammatory response syndrome in patients with a burdened comorbid background (type II diabetes mellitus, grade 3 arterial hypertension). During the examination of patients, it was shown that skin defects are foci of persistent bacteremia of representatives of the CoNS group, which can cause the development of a systemic inflammatory infectious response with the formation of resistant strains of the opportunistic flora of the microbiome of the skin and mucous membranes. It has been shown that to determine the tactics of antibacterial therapy, a bacteriological study of all detected foci of infection in patients, screening of pathogens and their sensitivity to antibiotics, and especially in persons at risk, is necessary. This will increase the effectiveness of antibacterial therapy and reduce the possibility of forming resistant strains of pathogens.

About the authors

Viktor V. Maleev

Central Research Institute of Epidemiology

Author for correspondence.
Email: maleyev@pcr.ru
ORCID iD: 0000-0001-5748-178X

акад. РАН, д-р мед. наук, проф., советник дир. по научной работе

Russian Federation, Moscow

Elena N. Lazareva

Central Research Institute of Epidemiology

Email: maleyev@pcr.ru
ORCID iD: 0000-0002-6081-1740

д-р мед. наук, вед. науч. сотр. клин. отд.

Russian Federation, Moscow

Zhanna B. Ponezheva

Central Research Institute of Epidemiology

Email: maleyev@pcr.ru
ORCID iD: 0000-0002-6539-4878

д-р мед. наук, зав. клин. отд. инфекционной патологии

Russian Federation, Moscow

Yulia V. Kuznetsova

Central Research Institute of Epidemiology

Email: maleyev@pcr.ru
ORCID iD: 0009-0007-5629-3972

ординатор клин. отд.

Russian Federation, Moscow

References

  1. Dadgostar P. Antimicrobial Resistance: Implications and Costs. Infect Drug Resist. 2019;20(12):3903-10. doi: 10.2147/IDR.S234610
  2. World Health Organization, Food and Agriculture Organization of the United Nations, United Nations Environment Programme and World Organisation for Animal Health, 2023. A one health priority research agenda for antimicrobial resistance. Available at: https://www.fao.org/3/cc6213en/cc6213en.pdf. Accessed: 21.02.2024.
  3. Рачина С.А., Федина Л.В., Сухорукова М.В., и др. Диагностика и антибактериальная терапия нозокомиальной пневмонии у взрослых: от рекомендаций к реальной практике. Терапевтический архив. 2023;95(11):996-1003 [Rachina SA, Fedina LV, Sukhorukova MV, et al. Diagnosis and antibiotic therapy of nosocomial pneumonia in adults: from recommendations to real practice. A review. Terapevticheskii Arkhiv (Ter. Arkh.). 2023;95(11):996-1003 (in Russian)]. doi: 10.26442/00403660.2023.11.202467
  4. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629-55. doi: 10.1016/S0140-6736(21)02724-0
  5. Grzebyk M, Brzychczy-Włoch M, Piotrowska A, et al. Phenotypic evaluation of hydrophobicity and the ability to produce biofilm in coagulase-negative staphylococci isolated from infected very-low-birth weight newborns. Med Dow Mikrobiol. 2013;65(3):149-59.
  6. Граничная Н.В., Зайцева Е.А., Пятко В.Э. Микробиологический мониторинг и антибиотикорезистентность коагулазонегативных стафилококков, выделенных от пациентов кардиохирургического стационара. Здоровье. Медицинская экология. Наука. 2017;1(68):24-9 [Borzhnaya NV, Zaitseva EA, Pyatkov E. Microbiological monitoring and antibiotic resistance of coagulase-negative staphylococci isolated from patients of a cardiac surgical hospital. Health. Medical Ecology. The Science. 2017;1(68):24-9 (in Russian)]. doi: 10.5281/zenodo.345607
  7. Michalik M, Samet A, Podbielska-Kubera A, et al. Coagulase-negative staphylococci (CoNS) as a significant etiological factor of laryngological infections: a review. Ann Clin Microbiol Antimicrob. 2020;19(26):2-10. doi: 10.1186/s12941-020-00367-x
  8. Kitaya Sh, Kanamori H, Katori Y, Tokuda K. Clinical Characteristics and Outcomes of Persistent Staphylococcal Bacteremia in a Tertiary Care Hospital. Antibiotics (Basel). 2023;12:454. doi: 10.3390/antibiotics12030454
  9. Stach N, Kaszycki P, Władyka B, Dubin G. Extracellular proteases of Staphylococcus spp. In: Pet-to-man travelling staphylococci. A world in progress, ed. V. Savini (Cambridge, MA: Elsevier), 2018; p. 135-45. doi: 10.1016/b978-0-12-81354 7-1.00011-x
  10. Paranthaman K, Wilson А, Verlander N, et al. Trends in coagulase-negative staphylococci (CoNS), England, 2010–2021. Access Microbiol. 2023;5(6):acmi000491.v3. doi: 10.1099/acmi.0.000491.v3
  11. Игнатова Г.Л., Блинова Е.В., Струч С.В., Сырочкина М.А. Риск развития внебольничной пневмонии у пациентов с сахарным диабетом. Терапевтический архив. 2022;94(3):448-53 [Ignatova GL, Blinova EV, Struch SV, Syrochkina MA. Risk of community acquired pneumonia in patients with diabetes mellitus: Review. Terapevticheskii Arkhiv (Ter. Arkh.). 2022;94(3):448-53 (in Russian)]. doi: 10.26442/00403660.2022.03.201447
  12. Barbier F, Lebeaux D, Hernandez D, et al. High prevalence of the arginine catabolic mobile element in carriage isolates of methicillin-resistant Staphylococcus epidermidis. J Antimicrob Chemother. 2011;66(1):29-36. doi: 10.1093/jac/dkq410
  13. Hardie KR. Antimicrobial resistance: the good, the bad, and the ugly. Emerg Top Life Sci. 2020;4(2):129-36. doi: 10.1042/ETLS20190194

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2024 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 
 


Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).